Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 1966; Volume 2,Issue 5

Articles

  • You have access
    Responses of Acetylcholinesterase from Torpedo marmorata to Salts and Curarizing Drugs
    JEAN-PIERRE CHANGEUX
    Molecular Pharmacology September 1966, 2 (5) 369-392;
  • You have access
    Heart Muscle Hexokinase: Subcellular Distribution and Inhibition by Glucose 6-Phosphate
    STEVEN E. MAYER, ANNETTE C. MAYFIELD and JOSEPH A. HAAS
    Molecular Pharmacology September 1966, 2 (5) 393-405;
  • You have access
    Ribonucleic Acid Polymerase Activity in Liver Nuclei from Rats Pretreated with 3-Methylcholanthrene
    EDWARD BRESNICK
    Molecular Pharmacology September 1966, 2 (5) 406-410;
  • You have access
    A Novel Irreversible Inhibitor of Acetylcholinesterase Specifically Directed at the Anionic Binding Site: Structure—Activity Relationships
    B. BELLEAU and H. TANI
    Molecular Pharmacology September 1966, 2 (5) 411-422;
  • You have access
    Purification and Properties of Folate Reductase, the Cellular Receptor of Amethopterin
    SIGMUND F. ZAKRZEWSKI, MAIRE T. HAKALA and CHARLES A. NICHOL
    Molecular Pharmacology September 1966, 2 (5) 423-431;
  • You have access
    Purine Ribonucleoside Kinase Activity and Resistance to Some Analogs of Adenosine
    L. LEE BENNETT, HANS P. SCHNEBLI, MARGARET H. VAIL, PAULA W. ALLAN and JOHN A. MONTGOMERY
    Molecular Pharmacology September 1966, 2 (5) 432-443;
  • You have access
    Inhibition of Protein Synthesis by Polypeptide Antibiotics III. Ribosomal Site of Inhibition
    HERBERT L. ENNIS
    Molecular Pharmacology September 1966, 2 (5) 444-453;
  • You have access
    Hormonal Effects on Glycogen Metabolism in the Rat Heart in Situ
    BETTY J WILLIAMS and STEVEN E MAYER
    Molecular Pharmacology September 1966, 2 (5) 454-464;
  • You have access
    Specific Protection of Folate Reductase Against Chemical and Proteolytic Inactivation
    MAIRE T. HAKALA and ELSE-MAJ SUOLINNA
    Molecular Pharmacology September 1966, 2 (5) 465-480;
  • You have access
    Control of Ammonia Formation From ATP in a Multienzyme System of Liver in Presence of Uncouplers of Oxidative Phosphorylation
    ERNEST KUN, HORACE H. LOH and S. B. I. EL-FIKY
    Molecular Pharmacology September 1966, 2 (5) 481-490;
  • You have access
    Factors Influencing the Metabolism and Distribution of Corticosterone-1,2-3H in the Rat
    R. P. MAICKEL, M. T. BUSH, W. R. JONDORF, F. P. MILLER and J. R. GILLETTE
    Molecular Pharmacology September 1966, 2 (5) 491-495;
  • You have access
    The Binding of Xenon to Sperm Whale Deoxymyoglobin
    B. P. SCHOENBORN and C. L. NOBBS
    Molecular Pharmacology September 1966, 2 (5) 495-498;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 2, Issue 5
1 Sep 1966
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics